Clive Peedell (@drpeedell.bsky.social)
Consultant Clinical Oncologist NHS advocate and campaigner Politically centre left Wealth inequality creates health inequality
Related Articles
Obinutuzumab and Liso-Cel Revisions to CLL/SLL NCCN Guidelines Mark Most Notable Changes of 2024
Matthew Cortese, MD, MPH, details 2024/2025 updates to the NCCN guidelines for CLL/SLL and treatments to look forward to in the future.
FDA Grants Orphan Drug Designation to LBL-034 for Multiple Myeloma
The FDA has granted orphan drug designation to LBL-034 for the treatment of patients with multiple myeloma.
NICHE-2: nivolumab and ipilimumab in non-metastatic MSI-high colon cancer
John Strickler, MD, Duke Cancer Institute, Durham, NC, gives an overview of the NICHE-2 trial (NCT03026140), which assessed immunotherapy for non-metastatic MSI-high colon cancer. Traditionally…
Lynne Nguyen (@disparityreport.bsky.social)
Plain language evangelist, health disparities, equitable access to clinical trials, community advocate
ASH Visitor Training Program
The Visitor Training Program (VTP) is intended to help build hematology capacity in developing countries by providing funding for hematologists or hematology-related health care professionals…
ASH Visitor Training Program
The Visitor Training Program (VTP) is intended to help build hematology capacity in developing countries by providing funding for hematologists or hematology-related health care professionals…
Advancements in Follicular Lymphoma Treatment With Targeted Therapies
At the 42nd Annual Chemotherapy Foundation Symposium, Erin Mulvey, MD, discussed the significant progress being made in the treatment of relapsed or refractory follicular lymphoma.
Notable 2024/Early 2025 Multiple Myeloma NCCN Guideline Updates Feature Quadruplets and More
Shaji Kumar, MD, details key updates/revisions made to the multiple myeloma NCCN guidelines in 2024 and the first version of the 2025 guidelines.
OCE Rare Cancers Program
Promoting development of new drug and biological products to treat patients with rare cancers
